Literature DB >> 12643379

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer.

Noriyoshi Sawabata1, Akihide Matsumura, Mitsunori Ohota, Hajime Maeda, Hiroshi Hirano, Katsuhiro Nakagawa, Hikaru Matsuda.   

Abstract

BACKGROUND: We have developed a novel test for the surgical margin of pulmonary malignant tumor using a cytologic technique (the run-across method in which a glass slide is run across the staple site), and we have assessed whether this method is useful in predicting margin relapse and prognosis.
METHODS: From April 1996 to March 1999, 15 lesions of stage I non-small cell lung cancer (NSCLC) (maximum diameter ranged from 10 to 35 mm with a median of 20 mm) from 15 patients with cardiopulmonary impairment were excised without additional proximal resections. The surgical margin was examined using the run-across method. There were 8 male 7 female patients whose ages ranged from 51 to 80 years. One patient underwent video-assisted thoracic surgery and 14 underwent thoracotomy. The preoperative diagnoses of the patients were 13 adenocarcinomas, 2 squamous cell carcinomas, and 1 undiagnosed lesion (1 adenocarcinoma). The follow-up period ranged from 37 to 63 months.
RESULTS: The rate of positive cytology was 47% in comparison with the rate of positive histology of 20%. There were 4 patients with margin relapse (3 of them contained negative histology margins) at a rate of 57% among the positive cytology patients in comparison with 0% among the negative cytology patients (p = 0.03). In a comparison of survival between the negative cytology group and the positive cytology group, there were no statistically significant differences.
CONCLUSIONS: The run-across method is also useful in confirming complete resection. A positive cytology margin could lead to margin relapse even if a non-small cell lung cancer is resected with a negative histology margin.

Entities:  

Mesh:

Year:  2002        PMID: 12643379     DOI: 10.1016/s0003-4975(02)03993-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Hajime Maeda; Akihide Matsumura; Mitsunori Ohta; Meinoshin Okumura
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.

Authors:  Hiran C Fernando; Rodney J Landreneau; Sumithra J Mandrekar; Francis C Nichols; Shauna L Hillman; Dwight E Heron; Bryan F Meyers; Thomas A DiPetrillo; David R Jones; Sandra L Starnes; Angelina D Tan; Benedict D T Daly; Joe B Putnam
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

3.  Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy.

Authors:  Mark R Waddle; Stephen Ko; Margaret M Johnson; Yanyan Lou; Robert C Miller; Anna C Harrell; Daniel M Trifiletti
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 4.  Emerging treatment options in the management of non-small cell lung cancer.

Authors:  Pier Luigi Filosso; Alberto Sandri; Alberto Oliaro; Andrea Riccardo Filippi; Maria Carla Cassinis; Umberto Ricardi; Paolo Olivo Lausi; Sofia Asioli; Enrico Ruffini
Journal:  Lung Cancer (Auckl)       Date:  2011-06-08

Review 5.  Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: can it be reduced by considering cancer cells at the surgical margin?

Authors:  Noriyoshi Sawabata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-29

6.  Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Akikazu Kawase; Nobumasa Takahashi; Takeshi Kawaguchi; Tetsukan Woo; Yuichi Saito; Satoshi Shiono; Noriyuki Matsutani
Journal:  Surg Today       Date:  2018-06-19       Impact factor: 2.549

7.  Optimal margins for early stage peripheral lung adenocarcinoma resection.

Authors:  Pan Yin; Bingqing Yue; Ji Zhang; Dong Liu; Dongyu Bai; Guang Zhao; Chutong Huang; Guojun Geng; Jie Jiang; Yongxiang Su; Xiuyi Yu; Jingyu Chen
Journal:  BMC Cancer       Date:  2021-05-11       Impact factor: 4.430

8.  Intraoperative computed tomography of a resected lung inflated with air to verify safety surgical margin.

Authors:  Go Kamimura; Kazuhiro Ueda; Soichi Suzuki; Koki Maeda; Hiroto Hakamada; Masami Sato
Journal:  Quant Imaging Med Surg       Date:  2022-02

Review 9.  [Progress of Lung Margin During Sublobar Resection for Early-staged Non-small Cell Lung Cancer].

Authors:  Zongkai Wang; Mingjian Ge
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.